Literature DB >> 9915097

Prescription to over-the-counter switch: a regulatory perspective.

R P Juhl1.   

Abstract

This paper discusses the origins of the over-the-counter (OTC) drug category and presents information about the process of switching a drug from prescription (Rx) to OTC status. It also reviews past and current drug laws in terms of how they relate to OTC drugs.

Mesh：

Substances：

Year:  1998        PMID： 9915097     DOI： 10.1016/s0149-2918(98)80015-5

Source DB:  PubMed          Journal:  Clin Ther        ISSN： 0149-2918            Impact factor:   3.393


  3 in total

1.  From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Authors:  Eva Barrenberg; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2017-03-28       Impact factor: 2.953

2.  A history of drug advertising: the evolving roles of consumers and consumer protection.

Authors:  Julie Donohue
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

Review 3.  Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG).

Authors:  Gunther Haag; Hans-Christoph Diener; Arne May; Christian Meyer; Hartmut Morck; Andreas Straube; Peter Wessely; Stefan Evers
Journal:  J Headache Pain       Date:  2010-12-23       Impact factor: 7.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.